Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ccop - Mayo Clinic Scottsdale Oncology Program
Scottsdale, Arizona, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Mayo Clinic Cancer Center
Rochester, Minnesota, United States
- Ccop - Northern New Jersey
Hackensack, New Jersey, United States
- Ccop - Oklahoma
Tulsa, Oklahoma, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2001
- Primary completion
- 30 Jun 2006
- Completion
- 30 Jun 2006
- Last update posted
- 14 Jul 2016
- Registered enrollment
- 36
- Registry id
- NCT00027573
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.